Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

Authors: Hussein A Tawbi, Peter A Forsyth, F Stephen Hodi, Christopher D Lao, Stergios J Moschos, Omid Hamid, Michael B Atkins, Karl Lewis, Reena P Thomas, John A Glaspy, Sekwon Jang, Alain P Algazi, Nikhil I Khushalani, Michael A Postow, Anna C Pavlick, Marc S Ernstoff, David A Reardon, Igor Puzanov, Ragini R Kudchadkar, Ahmad A Tarhini, Anne Sumbul, Jasmine I Rizzo, Kim A Margolin

Published: 2021-04-19

DOI: 10.1093/neuonc/noab094

Source: Full article

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

Abstract